Research conducted by Mass General Brigham supports clinical guidelines that indicate starting hormone therapy is safer when started close to the onset of menopause. Women have a higher likelihood of developing Alzheimer's disease (AD) compared to men, comprising two-thirds of the individuals aff
Women are more likely than men to develop Alzheimer’s disease (AD), with women making up two-thirds of the population living with AD. A new study, led by Mass General Brigham researchers, sheds light on the relationship between the risk of Alzheimer’s disease and age of menopause and use of hormone therapy (HT).